CleanTech Biofuels, Inc.

2019 Q4 Form 10-Q Financial Statement

#000143774919022675 Filed on November 13, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q4

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $0.00 $11.06K
YoY Change -100.0%
Cash & Equivalents $1.00 $11.06K
Short-Term Investments
Other Short-Term Assets $18.52K $41.65K
YoY Change -63.29% -30.58%
Inventory
Prepaid Expenses $18.52K $41.65K
Receivables
Other Receivables
Total Short-Term Assets $18.52K $52.71K
YoY Change -67.09% -21.59%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.169M $2.169M
YoY Change 0.0% -3.45%
TOTAL ASSETS
Total Short-Term Assets $18.52K $52.71K
Total Long-Term Assets $2.169M $2.169M
Total Assets $2.188M $2.222M
YoY Change -1.7% -3.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $426.9K $422.1K
YoY Change 0.78% -1.78%
Accrued Expenses $3.676M $3.416M
YoY Change 11.34% 14.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.340M $3.197M
YoY Change 5.63% 5.52%
Total Short-Term Liabilities $7.443M $7.035M
YoY Change 8.07% 9.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $7.443M $7.035M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $7.443M $7.035M
YoY Change 8.07% 9.24%
SHAREHOLDERS EQUITY
Retained Earnings -$12.80M -$12.36M
YoY Change 4.87% 5.71%
Common Stock $99.73K $99.33K
YoY Change 0.81% 1.74%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.255M -$4.813M
YoY Change
Total Liabilities & Shareholders Equity $2.188M $2.222M
YoY Change -1.7% -3.98%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q4

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q3 clth Accrued Payroll And Professional Fees
AccruedPayrollAndProfessionalFees
2117451
CY2018Q4 clth Accrued Payroll And Professional Fees
AccruedPayrollAndProfessionalFees
1975724
clth Common Stock Issued To Consultant Directors And Employee
CommonStockIssuedToConsultantDirectorsAndEmployee
1600
clth Common Stock Issued To Consultant Directors And Employee
CommonStockIssuedToConsultantDirectorsAndEmployee
23200
clth Divestiture Of An Investment
DivestitureOfAnInvestment
clth Divestiture Of An Investment
DivestitureOfAnInvestment
15877
clth Interest Income Net Of Accrued Write Off
InterestIncomeNetOfAccruedWriteOff
1706
clth Interest Income Net Of Accrued Write Off
InterestIncomeNetOfAccruedWriteOff
2588
clth Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
1600
clth Issuance Of Restricted Common Stock
IssuanceOfRestrictedCommonStock
23200
CY2019Q3 clth Minimum Capital Received Threshold Conversion Of Note
MinimumCapitalReceivedThresholdConversionOfNote
5000000
clth Noncash Loss On Divestiture Of Van Keuren Investment
NoncashLossOnDivestitureOfVanKeurenInvestment
clth Noncash Loss On Divestiture Of Van Keuren Investment
NoncashLossOnDivestitureOfVanKeurenInvestment
15877
CY2019Q3 clth Notes Receivables Restricted Common Stock
NotesReceivablesRestrictedCommonStock
45806
CY2018Q4 clth Notes Receivables Restricted Common Stock
NotesReceivablesRestrictedCommonStock
44100
CY2019Q3 clth Prepaid Compensation Costs Related To All Share Based Payments
PrepaidCompensationCostsRelatedToAllShareBasedPayments
0
CY2017Q3 clth Stock Granted For Services Shares Gross
StockGrantedForServicesSharesGross
3000000
CY2019Q3 clth Working Capital
WorkingCapital
-7400000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
426939
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
422053
CY2019Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7495557
CY2018Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7494357
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
-3922
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Document Type
DocumentType
10-Q
dei Entity Central Index Key
EntityCentralIndexKey
0001411036
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
100733409
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Registrant Name
EntityRegistrantName
CleanTech Biofuels, Inc.
dei Entity Shell Company
EntityShellCompany
false
dei Entity Small Business
EntitySmallBusiness
true
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99333409
CY2019Q3 us-gaap Common Stock Value
CommonStockValue
99733
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
99333
CY2018 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
86000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
86000000
CY2019Q3 us-gaap Assets
Assets
2187769
CY2018Q4 us-gaap Assets
Assets
2221958
CY2019Q3 us-gaap Assets Current
AssetsCurrent
18519
CY2018Q4 us-gaap Assets Current
AssetsCurrent
52708
CY2019Q3 us-gaap Cash
Cash
1
CY2018Q4 us-gaap Cash
Cash
11057
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11057
CY2017Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2505
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1
CY2018Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5828
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-11056
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
3323
CY2019Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
5450000
CY2018Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8750000
CY2019Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2007Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
240000000
CY2019Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99733409
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99333409
CY2019Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
99733409
CY2019Q3 us-gaap Due From Employees
DueFromEmployees
15000
CY2018Q4 us-gaap Due From Employees
DueFromEmployees
15000
CY2019Q3 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
1158000
CY2018Q4 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
1049000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
600000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
600000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
52866
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
49839
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
150237
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-201800
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-23133
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-14267
CY2019Q3 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
1569250
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2187769
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2221958
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
7442958
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
7035032
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
164698
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
4886
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
5040
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
345962
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
143505
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
CY2018Q4 us-gaap Indefinite Lived License Agreements
IndefiniteLivedLicenseAgreements
1569250
CY2019Q3 us-gaap Interest Expense
InterestExpense
71291
CY2018Q3 us-gaap Interest Expense
InterestExpense
66265
us-gaap Interest Expense
InterestExpense
200313
us-gaap Interest Expense
InterestExpense
191470
us-gaap Interest Paid Net
InterestPaidNet
3641
us-gaap Interest Paid Net
InterestPaidNet
CY2019Q3 us-gaap Interest Payable Current
InterestPayableCurrent
1558344
CY2018Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1440103
CY2019Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
CY2018Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
61000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
117000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72056
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-113677
us-gaap Net Income Loss
NetIncomeLoss
-442009
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-141527
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-169876
us-gaap Net Income Loss
NetIncomeLoss
-514778
CY2019Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-70712
CY2018Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-91677
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-198607
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-215089
CY2019Q3 us-gaap Notes Payable
NotesPayable
3340224
CY2018Q4 us-gaap Notes Payable
NotesPayable
3197152
CY2019Q3 us-gaap Notes Payable Current
NotesPayableCurrent
3340224
CY2018Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3197152
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-70815
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-78199
us-gaap Operating Income Loss
OperatingIncomeLoss
-243402
us-gaap Operating Income Loss
OperatingIncomeLoss
-299689
CY2019Q3 us-gaap Other Expenses
OtherExpenses
CY2018Q3 us-gaap Other Expenses
OtherExpenses
26207
us-gaap Other Expenses
OtherExpenses
us-gaap Other Expenses
OtherExpenses
26207
CY2019Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
579
CY2018Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
795
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1706
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2588
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
CY2019Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
18518
CY2018Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
41651
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
85000
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
117000
CY2019Q3 us-gaap Professional Fees
ProfessionalFees
17949
CY2018Q3 us-gaap Professional Fees
ProfessionalFees
28360
us-gaap Professional Fees
ProfessionalFees
93165
us-gaap Professional Fees
ProfessionalFees
134991
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
24000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12804673
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12362664
us-gaap Revenues
Revenues
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
5300000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
370000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5670000
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5300000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.10
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.11
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2016Q2 us-gaap Share Price
SharePrice
0.05
CY2020Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
0
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
3600000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
0.15
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3600000
CY2016Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
750000
CY2017Q2 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
100000
CY2017Q3 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
200000
us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
2000000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-5255189
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-4813074
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99733409
CY2018Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99033409
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
99511187
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
98722298

Files In Submission

Name View Source Status
0001437749-19-022675-index-headers.html Edgar Link pending
0001437749-19-022675-index.html Edgar Link pending
0001437749-19-022675.txt Edgar Link pending
0001437749-19-022675-xbrl.zip Edgar Link pending
clth-20190930.xml Edgar Link completed
clth-20190930.xsd Edgar Link pending
clth-20190930_cal.xml Edgar Link unprocessable
clth-20190930_def.xml Edgar Link unprocessable
clth-20190930_lab.xml Edgar Link unprocessable
clth-20190930_pre.xml Edgar Link unprocessable
clth20190930_10q.htm Edgar Link pending
ex_163891.htm Edgar Link pending
ex_163892.htm Edgar Link pending
ex_163893.htm Edgar Link pending
ex_163894.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending